Related Experiment Video
Updated: Jun 19, 2026

12:44
A General Method for Evaluating Incubation of Sucrose Craving in Rats
Published on: November 4, 2011
13.3K
Sucrose Solution Ingestion Exacerbates Dinitrofluorobenzene-Induced Allergic Contact Dermatitis in Rats.
Aya Fujii1, Ryuto Kimura1, Azumi Mori1
1Department of Nutrition, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe City 651-2180, Japan.
Nutrients
|June 27, 2024
Summary
High sugar intake, particularly sucrose, can worsen allergic dermatitis in rats by altering gut bacteria and reducing blood acetate. Supplementing with triacetin reversed these effects, suggesting a dietary link to this skin condition.
Area of Science:
- Immunology
- Microbiology
- Nutritional Science
Background:
- Allergic dermatitis prevalence is increasing globally, linked to high-fat and high-sugar diets.
- While sucrose intake is associated with allergic diseases like asthma, its specific impact on allergic dermatitis remains under-researched.
Purpose of the Study:
- To investigate the effects of sucrose consumption on allergic contact dermatitis in a rat model.
- To explore the underlying mechanisms, including gut microbiota alterations and short-chain fatty acid (SCFA) levels.
Main Methods:
- Rats were administered sucrose solution for 14 days to assess allergic contact dermatitis induced by 2,4-dinitrofluorobenzene (DNFB).
- Gut microbiota composition, cecal and fecal SCFA levels, and blood SCFA concentrations were analyzed.
- Triacetin was administered with sucrose to evaluate its potential to counteract adverse effects.
Main Results:
- Sucrose intake led to early exacerbation of DNFB-induced allergic dermatitis symptoms and altered gut microbiota.
- Blood acetate levels significantly decreased, while cecal and fecal SCFA levels remained unaffected.
- Triacetin supplementation prevented the early exacerbation of symptoms, indicating a protective role.
Conclusions:
- Sucrose consumption can negatively impact allergic contact dermatitis by altering gut microbiota and reducing blood acetate levels.
- The mechanism involves reduced SCFA absorption due to decreased intestinal sodium concentration, mediated by sodium-glucose transporter 1 (SGLT1) upregulation.
- Targeting acetate levels or sodium transport may offer therapeutic strategies for managing sucrose-exacerbated allergic dermatitis.

